You are here: Industry Insights > Pfizer

News List

European Commission approves Pfizer’s Cibinqo to treat adults with moderate-to-severe atopic dermatitis expresspharma
December 14, 2021
Cibinqo is a once-daily oral treatment with proven efficacy demonstrated in a large-scale clinical trial programme.
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older AmericanPharmaceuticalReview
December 13, 2021
Pfizer Inc. and BioNTech SE announced that the FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age and older. The booster dose is to be administered at...
FDA expands EUA to Covid-19 booster shot of Pfizer-BioNTech Pharmaceutical-Technology
December 13, 2021
The US Food and Drug Administration (FDA) has granted expanded emergency use authorization (EUA) to Pfizer and BioNTech’s Covid-19 booster vaccine for people aged 16 years and above.
Pfizer Covid vaccine provides partial protection against Omicron: Study expresspharma
December 10, 2021
The yet-to-be peer-reviewed study, posted on the pre-print repository medRxiv recently, also found that considerable immunity is retained in people who were both vaccinated and previously ...
FDA Approves Pfizer Boosters for Teens Aged 16 to 17 Drugs
December 10, 2021
The U.S. Food and Drug Administration on Thursday approved the emergency use of the Pfizer COVID-19 booster shots for Americans aged 16 and 17 years old.
FDA Authorises Emergency Use of Pfizer Boosters for Those Aged 16-17 Drugs
December 10, 2021
The U.S. Food and Drug Administration on Thursday approved the emergency use of Pfizer's coronavirus booster shots for Americans aged 16 and 17.
Canada enters deals to procure Merck and Pfizer’s Covid-19 antiviral pills Pharmaceutical-Technology
December 07, 2021
The Government of Canada has entered agreements with Merck and Pfizer to procure courses of their Covid-19 oral antiviral pills.
Pfizer accused of funding anti-AstraZeneca information FirstWordPharma
December 06, 2021
Pfizer, co-developer of the Comirnaty coronavirus vaccine, has been accused of funding educational presentations that claim AstraZeneca's rival shot was ineffective and even dangerous for some members of the population, reported CityAM.
UK study finds mRNA COVID-19 vaccines provide biggest booster impact expresspharma
December 03, 2021
The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's vaccine, while all seven increased immunity when given after two doses of AstraZeneca's vaccine.
AWS helps Pfizer accelerate drug development and clinical manufacturing WorldPharmaNews
December 03, 2021
Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page